Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil
- PMID: 15380275
- DOI: 10.1016/j.diagmicrobio.2004.04.009
Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil
Abstract
In this study, we describe resistance mechanisms in fluconazole-resistant isolates of C. albicans isolated from AIDS patients from nine Brazilian hospitals. These mechanisms include the presence of point mutations in the ERG11 gene and overexpression of ERG11, and several genes encoding efflux pumps, as measured by quantitative real-time reverse transcriptase polymerase chain reaction. Several fluconazole-resistant strains had multiple mechanisms of resistance. Four mutations previously described, Y132F, K143R, E266D, and V437I, were identified among the strains, whereas some isolates contained more than one mutation. Fourteen novel mutations were identified. Interestingly, all Brazilian fluconazole-resistant isolates showed homozygosity at mating-type loci (MTL) associated with fluconazole resistance. This is the first comprehensive assessment at molecular level of mechanisms of fluconazole resistance in C. albicans isolates from South America.
Similar articles
-
Drug resistance genes and trailing growth in Candida albicans isolates.J Antimicrob Chemother. 2004 Feb;53(2):217-24. doi: 10.1093/jac/dkh040. Epub 2003 Dec 19. J Antimicrob Chemother. 2004. PMID: 14688046
-
Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.J Antimicrob Chemother. 2008 Apr;61(4):798-804. doi: 10.1093/jac/dkn015. Epub 2008 Jan 24. J Antimicrob Chemother. 2008. PMID: 18218640
-
Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals.Mycoses. 2011 Mar;54(2):99-104. doi: 10.1111/j.1439-0507.2009.01766.x. Mycoses. 2011. PMID: 19732347
-
Fluconazole resistance in Candida albicans: a review of mechanisms.Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):69-77. Eur Rev Med Pharmacol Sci. 2004. PMID: 15267120 Review.
-
The genetic basis of fluconazole resistance development in Candida albicans.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):240-8. doi: 10.1016/s0925-4439(02)00087-x. Biochim Biophys Acta. 2002. PMID: 12084466 Review.
Cited by
-
Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity.Antimicrob Agents Chemother. 2013 Apr;57(4):1832-9. doi: 10.1128/AAC.02295-12. Epub 2013 Feb 4. Antimicrob Agents Chemother. 2013. PMID: 23380720 Free PMC article.
-
The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.J Clin Lab Anal. 2022 Feb;36(2):e24208. doi: 10.1002/jcla.24208. Epub 2022 Jan 8. J Clin Lab Anal. 2022. PMID: 34997991 Free PMC article.
-
Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases.J Fungi (Basel). 2021 Jan 20;7(2):67. doi: 10.3390/jof7020067. J Fungi (Basel). 2021. PMID: 33498194 Free PMC article. Review.
-
The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions.Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02586-18. doi: 10.1128/AAC.02586-18. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30783005 Free PMC article.
-
Structural basis for heterogeneous phenotype of ERG11 dependent Azole resistance in C.albicans clinical isolates.Springerplus. 2014 Nov 6;3:660. doi: 10.1186/2193-1801-3-660. eCollection 2014. Springerplus. 2014. PMID: 25512882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical